Vitamin D deficiency in dialysis patients: Effect of dialysis modality and implications on outcome

Journal of Renal Nutrition

Volumn 20, Issue 6, 2010, Pages 359-367

  Gracia Iguacel, Carolina ^a   Gallar, Paloma ^a   Qureshi, Abdul R ^b   Ortega, Olimpia ^a   Mon, Carmen ^a   Ortiz, Milagros ^a   Villarreal, Isabel ^a   Garcia Lacalle, Concepcion ^a   Olieta, Aniana ^a   Sánchez, Maria ^a   Herrero, Juan C ^a   Vigil, Ana ^a   Lindholm, Beng ^b   Carrero, Juan J ^b,c  

^a HOSPITAL SEVERO OCHOA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SPAIN; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; SPAIN; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77957931101     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.03.005     Document Type: Article

References (42)

1. Keith D.S., Nichols G.A., Gullion C.M., et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004, 164:659-663.
2. Wen C.P., Cheng T.Y., Tsai M.K., et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008, 371:2173-2182.
3. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
4. Stenvinkel P., Carrero J.J., Axelsson J., et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?. Clin J Am Soc Nephrol 2008, 3:505-521.
5. Ganesh S.K., Stack A.G., Levin N.W., et al. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001, 12:2131-2138.
6. Kalantar-Zadeh K., Kuwae N., Regidor D.L., et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006, 70:771-780.
7. Avesani C.M., Carrero J.J., Axelsson J., et al. Inflammation and wasting in chronic kidney disease: partners in crime. Kidney Int 2006, 70(Suppl):S8-S13.
8. Levin A., Bakris G.L., Molitch M., et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007, 71:31-38.
9. Jean G., Charra B., Chazot C. Vitamin D deficiency and associated factors in hemodialysis patients. J Ren Nutr 2008, 18:395-399.
10. Wolf M., Betancourt J., Chang Y., et al. Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 2008, 19:1379-1388.
11. Ravani P., Malberti F., Tripepi G., et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009, 75:88-95.
12. Wang A.Y., Lam C.W., Sanderson J.E., et al. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 2008, 87:1631-1638.
13. Michos E.D., Melamed M.L. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 2008, 11:7-12.
14. Mehrotra R., Kermah D., Budoff M., et al. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 2008, 3:1144-1151.
15. Cuppari L., Garcia-Lopes M.G. Hypovitaminosis D in chronic kidney disease patients: prevalence and treatment. J Ren Nutr 2009, 19:38-43.
16. Taskapan H., Ersoy F.F., Passadakis P.S., et al. Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol 2006, 66:247-255.
17. Shah N., Bernardini J., Piraino B. Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients. Perit Dial Int 2005, 25:362-366.
18. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
19. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42:S1-S201.
20. Sherman S.S., Hollis B.W., Tobin J.D. Vitamin D status and related parameters in a healthy population: the effects of age, sex, and season. J Clin Endocrinol Metab 1990, 71:405-413.
21. Matsuoka L.Y., Wortsman J., Haddad J.G., et al. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol 1991, 127:536-538.
22. Saraiva G.L., Cendoroglo M.S., Ramos L.R., et al. Influence of ultraviolet radiation on the production of 25 hydroxyvitamin D in the elderly population in the city of Sao Paulo (23 degrees 34'S). Brazil. Osteoporos Int 2005, 16:1649-1654.
23. Vieth R., Cole D.E., Hawker G.A., et al. Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 2001, 55:1091-1097.
24. Wolf M., Shah A., Gutierrez O., et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007, 72:1004-1013.
25. Ewers B., Gasbjerg A., Moelgaard C., et al. Vitamin D status in kidney transplant patients: need for intensified routine supplementation. Am J Clin Nutr 2008, 87:431-437.
26. Jean G., Terrat J.C., Vanel T., et al. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant 2008, 23:3670-3676.
27. Carrero J.J. Identification of patients with eating disorders: clinical and biochemical signs of appetite loss in dialysis patients. J Ren Nutr 2009, 19:10-15.
28. Chmielewski M., Carrero J.J., Stenvinkel P., et al. Metabolic abnormalities in chronic kidney disease that contribute to cardiovascular disease, and nutritional initiatives that may diminish the risk. Curr Opin Lipidol 2009, 20:3-9.
29. Mak R.H., Cheung W., Cone R.D., et al. Mechanisms of disease: cytokine and adipokine signaling in uremic cachexia. Nat Clin Pract Nephrol 2006, 2:527-534.
30. Lee S.W., Russell J., Avioli L.V. 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol: conversion impaired by systemic metabolic acidosis. Science 1977, 195:994-996.
31. Prosser D.E., Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004, 29:664-673.
32. Mak R.H. Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int 1998, 54:603-607.
33. Cannata-Andia J.B., Gomez Alonso C. Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failure. Nephrol Dial Transplant 2002, 17:1875-1878.
34. Chen H., McCoy L.F., Schleicher R.L., et al. Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. Clin Chim Acta 2008, 391:6-12.
35. White P., Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000, 11:320-327.
36. Fehrman-Ekholm I., Lotsander A., Logan K., et al. Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with hemodialysis and on-line hemodiafiltration or hemofiltration. Scand J Urol Nephrol 2008, 42:74-80.
37. Vanholder R., De Smet R., Glorieux G., et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003, 63:1934-1943.
38. Gil C., Lucas C., Possante C., et al. On-line haemodiafiltration decreases serum TNFalpha levels in haemodialysis patients. Nephrol Dial Transplant 2003, 18:447-448.
39. Van Tellingen A., Grooteman M.P., Bartels P.C., et al. Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients. Kidney Int 2001, 59:342-347.
40. Beerenhout C.H., Luik A.J., Jeuken-Mertens S.G., et al. Pre-dilution on-line haemofiltration vs low-flux haemodialysis: a randomized prospective study. Nephrol Dial Transplant 2005, 20:1155-1163.
41. Penne E.L., Blankestijn P.J., Bots M.L., et al. Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients-the Dutch convective transport study (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]. Curr Control Trials Cardiovasc Med 2005, 6:8.
42. Mandolfo S., Borlandelli S., Imbasciati E. Leptin and beta2-microglobulin kinetics with three different dialysis modalities. Int J Artif Organs 2006, 29:949-955.